Variable | Survival status | Crude HR (95% CI) | Adjusted HR (95% CI) | |
---|---|---|---|---|
Died | Censored | |||
Age | ||||
< 1yr | 4 | 18 | 1 | |
1-5 yr | 10 | 187 | 0.25(0.08, 0.79) | * |
5 -15 yr | 27 | 303 | 0.38(0.13, 1.09) | * |
Sex | ||||
Male | 17 | 269 | 0.66 (0.35, 1.22) | * |
Female | 24 | 239 | 1 | |
OIs | ||||
Yes | 20 | 145 | 2.01 (1.09, 3.72) | * |
No | 21 | 363 | 1 | |
Cotrimoxazole preventive therapy | ||||
Yes | 8 | 279 | 1 | 1 |
No | 33 | 229 | 4.89(2.26,10.59) | 4.74 (2.17, 10.34) |
Developmental history | ||||
Appropriate | 34 | 497 | 1 | 1 |
Delayed/regressing | 7 | 11 | 10.13(4.43, 23.1) | 6.31(2.52, 15.83) |
WHO staging | ||||
I/II | 8 | 165 | 0.28(0.11, 0.72) | * |
III | 23 | 294 | 0.43(0.21, 0.91) | * |
IV | 10 | 49 | 1 | |
Haemoglobin (n = 520) | ||||
<10gm/dl | 15 | 88 | 2.87(1.5, 5.5) | 2.44 (1.26, 4.73) |
≥10gm/dl | 24 | 393 | 1 | 1 |
Nutritional status | ||||
Underweight | 39 | 414 | 3.89(0.94, 16.1) | * |
Normal | 2 | 94 | 1 | |
CD4 cell count | ||||
CD4 count below the threshold | 30 | 259 | 2.55(1.28, 5.1) | 2.24(1.07, 4.69) |
CD4 count above the threshold | 11 | 249 | 1 | 1 |